comparemela.com
  1. Home
  2. Live Updates
  3. Mets Phase - Breaking News

Mets Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3

– MB-106 AML Phase 1B/2 trial (MB-106) preliminary data readout: Reached 67% recruitment – MB-106 preliminary results: Intent to Treat CR rate of 40% plus a.

United statesJenene thomasWalter klempTacaribe arenavirusNational institutes of healthNorthwestern universityExchange commissionSecurities exchangeMoleculin biotech incDosed per protocolMets phaseMoleculin biotechChief executive officerEnd annamycin clinical trialsUpcoming milestonesNational institutes

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.